Additional File 1: of Systems Biology Analysis Reveals New Insights into Invasive Lung Cancer

Dan Li,William Yang,Carolyn Arthur,Jun Li,Carolina Cruz-Niera,Mary Qu Yang

DOI: https://doi.org/10.6084/m9.figshare.7470365

2018-01-01

Abstract:Figure S1. The hierarchical clustering of the 18 normal (blue), AIS (orange), and invasive samples (purple) based on gene expression. (XLSX 50 kb)

What problem does this paper attempt to address?

Figure S1 from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors

Michael K. Asiedu,Charles F. Thomas,Jie Dong,Sandra C. Schulte,Prasidda Khadka,Zhifu Sun,Farhad Kosari,Jin Jen,Julian Molina,George Vasmatzis,Ray Kuang,Marie Christine Aubry,Ping Yang,Dennis A. Wigle

DOI: https://doi.org/10.1158/1078-0432.22465187.v1

2023-01-01

Abstract:Pathway analysis of significantly mutated genes
Additional File 1 of Integration of Single-Cell Regulon Atlas and Multi-Omics Data for Prognostic Stratification and Personalized Treatment Prediction in Human Lung Adenocarcinoma

Yi Xiong,Yihao Zhang,Yu Yao,Yueshuo Li,Hongwei Liu,Qian Yang,Yu Chen,Xia Zhang,Xin Chen,Siyi Wanggou,Xuejun Li

DOI: https://doi.org/10.6084/m9.figshare.23751836

2023-01-01

Abstract:Additional file 1: Table S1. Basic information of included datasets. Table S2. Identification of prognostic regulons. Table S3. LPRI of all included datasets.
Supplementary Materials 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Lang,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524615.v1

2023-01-01

Abstract:PDF file - 129K, Sweave report depicting complete codes use for microarray analysis of paired adjacent and contralateral airways
Supplementary Figures 1 - 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Liu,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Mao Li,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524624

2023-01-01

Abstract:PDF file - 125K, Histograms of the p-values for site- and time-dependent differential expression; Site-dependent differential gene expression patterns identified by expression profiling of airways excluding main carinas; Smoothened scatter plot of transformed p-values for site and time effects
Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Lang,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524609.v1

2023-01-01

Abstract:XLSX file - 68K, Supplementary table depicting 1165 genes significantly differentially expressed by site in the molecular field of injury
Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Liu,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Mao Li,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524618.v1

2023-01-01

Abstract:PDF file - 6272K, Sweave report depicting complete codes used for microarray analysis and identification of genes differentially expressed by site and time
Additional File 6 of A Human Lung Tumor Microenvironment Interactome Identifies Clinically Relevant Cell-Type Cross-Talk

Andrew J. Gentles,Angela Bik‐Yu Hui,Weiguo Feng,Armon Azizi,Ramesh V. Nair,Gina Bouchard,David A. Knowles,Alice L. Yu,Youngtae Jeong,Alborz Bejnood,Erna Forgó,Sushama Varma,Yue Xu,Amanda Kuong,Viswam S. Nair,Robert B. West,Matt van de Rijn,Chuong D. Hoang,Maximilian Diehn,Sylvia K. Plevritis

DOI: https://doi.org/10.6084/m9.figshare.12270101

2020-01-01

Abstract:Table S6. Differences between average gene expression across transcriptome in bulk vs. reconstructed profiles. Relevant to Fig. 1e.
Comprehensive Analysis Of Pulmonary Adenocarcinoma In Situ (Ais) Revealed New Insights Into Lung Cancer Progression

Dan Li,William Yang,Yifan Zhang,Jack Y. Yang,Weida Tong,Renchu Guan,Mary Qu Yang

DOI: https://doi.org/10.1109/BIBM.2017.8217756

2017-01-01

Abstract:Pulmonary adenocarcinoma in situ (AIS) is an intermediate subtype of lung adenocarcinoma that exhibits non-invasive growth patterns, but can develop into invasive. Almost 100% of AIS patients can be cured with complete resection. In contrast, the five-year survival rate for those diagnosed with invasive lung adenocarcinoma is only about 4%. In order to get a better understanding of adenocarcinoma and identify marks indicating its evaluation and progression, what needs to be done is a genome-wide evaluation of the disease. In this study, we used RNA-seq data from normal, AIS, and invasive lung cancer samples to identify gene module with differential gene expressions that represents the properties of AIS, distinct from normal and invasive tumor. Utilizing the differential expression patterns of protein-coding genes and long non-coding RNAs (lncRNAs) between AIS and other conditions, we obtained a small group of 72 AIS-specific genes consisting 41 protein-coding genes, 5 annotated lncRNAs, and 26 novel lncRNA transcripts that expressed specifically in AIS samples. We consider that twelve of the protein-coding genes are lung cancer driver genes with located driver somatic mutations. Moreover, these AIS-specific genes show capabilities (98% accuracy in an independent data set) for indicating early stage lung cancer and normal situations. These genes are determined based on cell-adhesion functioning, including angiogenesis and fibronectin, etc., that are highly related to cancer development. The comparison of AIS with normal and invasive tumor provides the gene list revealing the mechanisms that accounts for AIS progression to invasive cancer. Furthermore we identified important signatures contributing to the early diagnosis of lung cancer, providing auxiliary studies to our ongoing precision medicine research (http://americancse.org/events/csce2017/keynotes_lectures/yang_talk).
Supplementary Figures S1-S21 from Integrated Multi-Omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness

Maria-Fernanda Senosain,Yong Zou,Khushbu Patel,Shilin Zhao,Alexis Coullomb,Dianna J Rowe,Jonathan M Lehman,Jonathan Michael Irish,Fabien Maldonado,Michael N Kammer,Vera Pancaldi,Carlos F Lopez

DOI: https://doi.org/10.1158/2767-9764.23642650.v1

2023-01-01

Abstract:Supplementary Figures S1-S21
Additional File 5 of Molecular Profiling of Human Non-Small Cell Lung Cancer by Single-Cell RNA-seq

Qingqing Li,Rui Wang,Zhenlin Yang,Lu Wen,Jingwei Yang,Zhijie Wang,Hua Bai,Yueli Cui,Yanhua Tian,Zixin Wu,Yuqing Guo,Jiachen Xu,Jie He,Fuchou Tang,Jie Wang

DOI: https://doi.org/10.6084/m9.figshare.20484657

2022-01-01

Abstract:Additional file 5: Table S5. Differentially expressed genes between siAKR1B1 and NC samples.
Additional File 1 of Metabolic Classifications of Renal Cell Carcinoma Reveal Intrinsic Connections with Clinical and Immune Characteristics

Le Li,Zheng Chao,Un Waikeong,Jun Xiao,Yili Ge,Yanan Wang,Zezhong Xiong,Sheng Ma,Zhihua Wang,Zhiquan Hu,Xing Zeng

DOI: https://doi.org/10.6084/m9.figshare.22610398

2023-01-01

Abstract:Additional file 1. Gsea results of 3 clusters.
Additional File 2 of IRGS: an Immune-Related Gene Classifier for Lung Adenocarcinoma Prognosis

Xiaoshun Shi,Ruidong Li,Xiaoying Dong,Allen M. Chen,Xiguang Liu,Daru Lu,Siyang Feng,He Wang,Kaican Cai

DOI: https://doi.org/10.6084/m9.figshare.11805678

2020-01-01

Abstract:Additional file 2: Table S1. Differentially expressed genes in the TCGA-LUAD dataset.
Additional File 8 of Breast Metastatic Tumors in Lung Can Be Substituted by Lung-Derived Malignant Cells Transformed by Alternative Splicing H19 Lncrna

Jin Biao Xu,Ji Cao,Ying Zhu,Yi He,Xin Jin,Mingguo Cao,Bing Mu Fang,Jean Paul Thiery,Zhou Weiyuan

DOI: https://doi.org/10.6084/m9.figshare.23265114

2023-01-01

Abstract:Additional file 8. Data file S1: PCR array plate layout.
Supplementary Fig S21-S24 from Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Ansam Sinjab,Guangchun Han,Warapen Treekitkarnmongkol,Kieko Hara,Patrick M. Brennan,Minghao Dang,Dapeng Hao,Ruiping Wang,Enyu Dai,Hitoshi Dejima,Jiexin Zhang,Elena Bogatenkova,Beatriz Sanchez-Espiridion,Kyle Chang,Danielle R. Little,Samer Bazzi,Linh M. Tran,Kostyantyn Krysan,Carmen Behrens,Dzifa Y. Duose,Edwin R. Parra,Maria Gabriela Raso,Luisa M. Solis,Junya Fukuoka,Jianjun Zhang,Boris Sepesi,Tina Cascone,Lauren Averett Byers,Don L. Gibbons,Jichao Chen,Seyed Javad Moghaddam,Edwin J. Ostrin,Daniel Rosen,John V. Heymach,Paul Scheet,Steven M. Dubinett,Junya Fujimoto,Ignacio I. Wistuba,Christopher S. Stevenson,Avrum Spira,Linghua Wang,Humam Kadara

DOI: https://doi.org/10.1158/2159-8290.22539754

2023-01-01

Abstract:Supplementary Figures S21-S24 and figure legends
Additional File 8 of IRGS: an Immune-Related Gene Classifier for Lung Adenocarcinoma Prognosis

Xiaoshun Shi,Ruidong Li,Xiaoying Dong,Allen M. Chen,Xiguang Liu,Daru Lu,Siyang Feng,He Wang,Kaican Cai

DOI: https://doi.org/10.6084/m9.figshare.11805717

2020-01-01

Abstract:Additional file 8: Table S5. Significantly enriched immune pathways of gene in the IRGS model.
Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature

Dan Li,William Yang,Yifan Zhang,Jack Y Yang,Renchu Guan,Dong Xu,Mary Qu Yang

DOI: https://doi.org/10.1186/s12920-018-0413-3

2018-11-01

BMC Medical Genomics

Abstract:BackgroundNon-small cell lung cancer (NSCLC) represents more than about 80% of the lung cancer. The early stages of NSCLC can be treated with complete resection with a good prognosis. However, most cases are detected at late stage of the disease. The average survival rate of the patients with invasive lung cancer is only about 4%. Adenocarcinoma in situ (AIS) is an intermediate subtype of lung adenocarcinoma that exhibits early stage growth patterns but can develop into invasion.MethodsIn this study, we used RNA-seq data from normal, AIS, and invasive lung cancer tissues to identify a gene module that represents the distinguishing characteristics of AIS as AIS-specific genes. Two differential expression analysis algorithms were employed to identify the AIS-specific genes. Then, the subset of the best performed AIS-specific genes for the early lung cancer prediction were selected by random forest. Finally, the performances of the early lung cancer prediction were assessed using random forest, support vector machine (SVM) and artificial neural networks (ANNs) on four independent early lung cancer datasets including one tumor-educated blood platelets (TEPs) dataset.ResultsBased on the differential expression analysis, 107 AIS-specific genes that consisted of 93 protein-coding genes and 14 long non-coding RNAs (lncRNAs) were identified. The significant functions associated with these genes include angiogenesis and ECM-receptor interaction, which are highly related to cancer development and contribute to the smoking-free lung cancers. Moreover, 12 of the AIS-specific lncRNAs are involved in lung cancer progression by potentially regulating the ECM-receptor interaction pathway. The feature selection by random forest identified 20 of the AIS-specific genes as early stage lung cancer signatures using the dataset obtained from The Cancer Genome Atlas (TCGA) lung adenocarcinoma samples. Of the 20 signatures, two were lncRNAs, BLACAT1 and CTD-2527I21.15 which have been reported to be associated with bladder cancer, colorectal cancer and breast cancer. In blind classification for three independent tissue sample datasets, these signature genes consistently yielded about 98% accuracy for distinguishing early stage lung cancer from normal cases. However, the prediction accuracy for the blood platelets samples was only 64.35% (sensitivity 78.1%, specificity 50.59%, and AUROC 0.747).ConclusionsThe comparison of AIS with normal and invasive tumor revealed diseases-specific genes and offered new insights into the mechanism underlying AIS progression into an invasive tumor. These genes can also serve as the signatures for early diagnosis of lung cancer with high accuracy. The expression profile of gene signatures identified from tissue cancer samples yielded remarkable early cancer prediction for tissues samples, however, relatively lower accuracy for boold platelets samples.

genetics & heredity
Additional File 1 of Precision Treatment Exploration of Breast Cancer Based on Heterogeneity Analysis of Lncrnas at the Single-Cell Level

Yan Zhang,Denan Zhang,Qingkang Meng,Ziqi Liu,Hongbo Xie,Lei Liu,Fei Xu,Xiujie Chen

DOI: https://doi.org/10.6084/m9.figshare.15178652

2021-01-01

Abstract:Additional file 1. Density matrix.zip.
Additional File 3 of Exploration of Predictive and Prognostic Alternative Splicing Signatures in Lung Adenocarcinoma Using Machine Learning Methods

Qidong Cai,Boxue He,Pengfei Zhang,Zhenyu Zhao,Ping Xiong,Yuqian Zhang,Haiyang Xie,Xiang Wang

DOI: https://doi.org/10.6084/m9.figshare.13346463

2020-01-01

Abstract:Additional file 3: Table S3. Samples for recognizing lymph node metastasis (LNM).
Additional File 3: Table S2. of Comprehensive Analyses of Tumor Immunity: Implications for Cancer Immunotherapy

Bo Li,Eric A. Severson,Jean‐Christophe Pignon,Haoquan Zhao,Taiwen Li,Jesse Novak,Peng Jiang,Hui Shen,Jon C. Aster,Scott J. Rodig,Sabina Signoretti,Jun S. Liu,Xianglei Liu

DOI: https://doi.org/10.6084/m9.figshare.c.3597833_d10

2016-01-01

Abstract:Immune infiltration estimation. (XLSX 2364 kb)
Additional File 3 of Construction of a Predictive Model for Immunotherapy Efficacy in Lung Squamous Cell Carcinoma Based on the Degree of Tumor-Infiltrating Immune Cells and Molecular Typing

Lingge Yang,Shuli Wei,Jingnan Zhang,Qiongjie Hu,Wansong Hu,Mengqing Cao,Long Zhang,Yongfang Wang,Pingli Wang,Kai Wang

DOI: https://doi.org/10.6084/m9.figshare.20484975

2022-01-01

Abstract:Additional file 3: Table S2. The main clinical information of TCGA-LUSC, GSE126044, GSE135222 and our independent LUSC cohort.

Additional File 1: of Systems Biology Analysis Reveals New Insights into Invasive Lung Cancer

Figure S1 from Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors

Additional File 1 of Integration of Single-Cell Regulon Atlas and Multi-Omics Data for Prognostic Stratification and Personalized Treatment Prediction in Human Lung Adenocarcinoma

Supplementary Materials 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Figures 1 - 3 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Supplementary Materials 2 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Additional File 6 of A Human Lung Tumor Microenvironment Interactome Identifies Clinically Relevant Cell-Type Cross-Talk

Comprehensive Analysis Of Pulmonary Adenocarcinoma In Situ (Ais) Revealed New Insights Into Lung Cancer Progression

Supplementary Figures S1-S21 from Integrated Multi-Omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness

Additional File 5 of Molecular Profiling of Human Non-Small Cell Lung Cancer by Single-Cell RNA-seq

Additional File 1 of Metabolic Classifications of Renal Cell Carcinoma Reveal Intrinsic Connections with Clinical and Immune Characteristics

Additional File 2 of IRGS: an Immune-Related Gene Classifier for Lung Adenocarcinoma Prognosis

Additional File 8 of Breast Metastatic Tumors in Lung Can Be Substituted by Lung-Derived Malignant Cells Transformed by Alternative Splicing H19 Lncrna

Supplementary Fig S21-S24 from Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Additional File 8 of IRGS: an Immune-Related Gene Classifier for Lung Adenocarcinoma Prognosis

Genomic analyses based on pulmonary adenocarcinoma in situ reveal early lung cancer signature

Additional File 1 of Precision Treatment Exploration of Breast Cancer Based on Heterogeneity Analysis of Lncrnas at the Single-Cell Level

Additional File 3 of Exploration of Predictive and Prognostic Alternative Splicing Signatures in Lung Adenocarcinoma Using Machine Learning Methods

Additional File 3: Table S2. of Comprehensive Analyses of Tumor Immunity: Implications for Cancer Immunotherapy

Additional File 3 of Construction of a Predictive Model for Immunotherapy Efficacy in Lung Squamous Cell Carcinoma Based on the Degree of Tumor-Infiltrating Immune Cells and Molecular Typing